Close
FINDING CURES TOGETHER<sup>SM</sup>

​​​Current ​MEG Announcements

AACR Council Service Opportunities Coming Soon

In the next few weeks, all three AACR constituency groups [Associate Member Council (AMC); Minorities in Cancer Research (MICR); and Women in Cancer Research (WICR)] will begin to accept applications/nominations for council service. This is an exciting opportunity to get more involved with the AACR, its programs and initiatives for members. More information for each group's opportunities will be announced on the AACR-Constituency Groups website, in the very near future.  We look forward to your valuable participation!

Request for Proposals for Genome-wide Investigation of Late-effects using the Childhood Cancer Survivor Study (CCSS) Cohort

The Childhood Cancer Survivor Study (CCSS) is an NCI-funded resource for the study of long-term survivors of cancer diagnosed during childhood and adolescence. Learn the details regarding the cohort.

Members of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute and CCSS investigators collaborated to conduct a genome-wide association study, initially intended to study the role of genetic susceptibility in the development of subsequent neoplasms as well as first primary childhood cancers using samples from the CCSS Biorepository. Genotyping was conducted for 5739 childhood cancer survivors diagnosed 1970-1986 (5324 are of European ancestry) using the Illumina HumanOmni5Exome microarray, with over 4.1 million loci passing quality control thresholds (based on locus and sample missing rates, sample heterozygosity, and sex discrepancies).
 
The CCSS leadership is now broadening the scope of this initiative to study the role of genetic susceptibility in the development of non-malignant, treatment-related outcomes in cancer survivors. Accordingly, CCSS is announcing a request for proposals to collaborate with CCSS and NCI investigators in the use of existing genome-wide association study (GWAS) data and corresponding outcomes-related data to address innovative research questions relating to potential genetic contributions to risk for non-malignant treatment-related outcomes. Requests will be accepted on an ongoing basis and will be reviewed three times per year, in February, June, and October (cut-off for receipt of applications February 1, June 1, October 1).
 
Learn more details regarding the application process as well as the application for data access.

From the Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute

The Epidemiology and Genomics Research Program in NCI’s Division of Cancer Control and Population Sciences invites AACR-MEG members to register for upcoming webinars.

To learn more about the EGRP's webinar series, visit the SeqSPACE Upcoming Topics and Speakers webpage.

Registration open for the following webinars:

Analyzing Large Scale Sequenced Based Epidemiological Studies
Sept. 27, 2017, at 3 - 4:30 p.m. ET

Speaker: Suzanne Margaret Leal, PhD
Professor, Molecular and Human Genetics, Baylor College of Medicine
Adjunct Professor, Department of Statistics, Rice University
Senior Research Associate, The Rockefeller University

Dr. Suzanne Leal is a professor in the Department of Molecular and Human Genetics at Baylor College of Medicine and director of the Center for Statistical Genetics, an adjunct professor in the Department of Statistics at Rice University, and a senior research associate at The Rockefeller University. Her primary research interests are statistical genetics and genetic epidemiology. Currently, Dr. Leal's concentration is in the development of methods to analyze rare variants. In addition to applied work, mapping disease\trait loci, she has worked extensively in developing methods to aid in gene identification and understanding disease etiology. Dr. Leal will be presenting on software for analyzing sequencing-based epidemiological studies and rare variant aggregation association tests.
Register for this webinar.

Informatics Tools for Analysis of Next Generation Sequencing Studies Supported by the NCI ITCR Program
November 14, 2017; 1 – 2:30 p.m. ET

Speakers and Informatic Tools:
Aviv Regev, PhD
Professor of Biology, MIT; Core Member, Broad Institute; Investigator, Howard Hughes Medical Institute
Informatic Tool: TRINITY, a toolkit for analysis of RNA sequencing data and cancer transcriptomes.

Michael Ryan, PhD
Founder, In Silico Solutions
Informatic Tools: CRAVAT and MuPIT, tools to use and integrate a variety of functional annotations and structural information for interpretation of genetic variants.

Obi Griffith, PhD
Assistant Professor of Medicine, Washington University; Assistant Director, McDonnell Genome Institute
Informatic Tool: CIViC, a resource for the clinical interpretation of variants in cancer.

NCI's Information Technology for Cancer Research (ITCR) program promotes research-driven informatics technology across the development lifecycle to address priority needs in cancer research. ITCR supports a wide range of informatics tools to serve current and emerging needs across the cancer research continuum. We invite you to join us for a SeqSPACE panel of speakers that will highlight several of the informatics tools from ITCR useful for next generation sequencing applications including transcriptomics and functional and clinical interpretation of variants.
Register for this webinar.

MEG Members Receive an Additional 5 Percent Discount on CEBP Accepted Manuscripts

MEG members receive a special 5 percent discount on Cancer Epidemiology, Biomarkers & Prevention (CEBP) publication charges. This discount is in addition to the AACR member discount of 5 percent. Thus, MEG members receive a total discount of 10 percent. Just use the code “MEGAO17” when receiving notification about author billing. See the information for authors for CEBP submissions. We look forward to receiving your submission.

CancerCareers Discounts Available

Be sure to check out the new www.cancercareers.org website for career opportunities. MEG members now receive a 15 percent discount for all employment postings. Use the code MEGAD when submitting your advertisement to receive this special rate. You can also sign-up for job alerts and refine a job search by a specific research area, i.e. epidemiology; prevention. Look on the right side of the website for these options.

To submit an announcement for consideration, please note:

Employment opportunities should be sent to cancercareers.org for posting consideration on that website. Please refer all questions regarding employment posting to Custom​erService@CancerCareers.org.

Postings of a non-employment nature may still be sent to meg@aacr.org for review and possible future posting on the MEG Announcements.

Best regards from everyone at the AACR, and sincere appreciation for your
AACR-MEG Membership.